Side-by-side research comparison of GHRP-2 and GHRP-6 across our PubMed, ClinicalTrials.gov, and EuropePMC corpus. 12 head-to-head studies plus 67 on GHRP-2 and 82 on GHRP-6.
| GHRP-2 | GHRP-6 | |
|---|---|---|
| Drug class | ghrelin mimetic | ghrelin mimetic |
| Studies in corpus | 67 | 82 |
| Highest evidence tier | cohort | rct |
| Evidence tier mix | other · 7 preclinical animal · 15 case report · 4 cohort · 1 case series · 1 review · 5 in vitro · 5 | in vitro · 13 preclinical animal · 45 other · 8 rct · 1 review · 1 |
| Studies with explicit sample size | 14 | 3 |
| Head-to-head studies in corpus | 12 | |
Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real GHRP-2 and GHRP-6 batches we've tested. Aggregate, public data — cross-reference against the studies below.
We tested 124 GHRP-2 batches across 56 manufacturers, 99.31% avg purity.
We tested 160 GHRP-6 batches across 75 manufacturers, 99.51% avg purity.
We hold deeper lab coverage on GHRP-6 (160 batches tested). GHRP-6 edges ahead on average measured purity (99.31% vs 99.51%) — a narrow gap; weigh it against failed-batch and underdose counts above.
Studies in our corpus that mention both GHRP-2 and GHRP-6 — the gold-standard direct comparison evidence.
For clinicians and individuals managing hypogonadism, this review positions GHS like ipamorelin as a potential next-frontier adjunctive therapy to testosterone, specifically for targeting body composition issues like stubborn fat and muscle loss. The key im…
**Clinicians managing thalassemia-related growth failure** should note that standard stimulation testing may miss subnormal ultradian GH secretion, meaning affected patients could benefit from secretagogue-based protocols despite 'normal' diagnostic workups…
This advanced analytical method provides a crucial tool for anti-doping agencies to combat the illicit use of GHRPs in both equine and human sports. By enabling reliable and high-throughput detection, it helps ensure fair competition and protects athlete he…
**GHRPs — particularly hexarelin — should be understood as direct cardiac agents**, not merely GH secretagogues; clinicians and researchers evaluating these compounds for body composition or GH-axis support must account for concurrent cardiovascular effects…
**GHS compounds including GHRP-2, GHRP-6, and MK-677 target four converging GH-axis nodes simultaneously**, which explains their superior efficacy over single-mechanism secretagogues and provides a pharmacological rationale for their clinical and off-label …
This research provides a foundational understanding of which structural parts of GHRPs like Ipamorelin are critical for their function. For peptide users, this knowledge explains why certain analogues are more or less potent. For anti-doping science, it's a…
For anti-doping analysts and forensic toxicologists, this study validates a practical and ethical method for identifying new biomarkers of peptide abuse. Instead of relying on difficult-to-conduct human trials, labs can use commercially available liver frac…
This groundbreaking discovery represents a significant new challenge for global anti-doping agencies and laboratories, as these glycine-modified GHSs are unlikely to be detected by current, standard screening protocols. The identification of these novel mod…
These findings directly inform and improve anti-doping testing protocols. By identifying specific, long-lasting metabolites for each GHRP, labs can create more robust screening methods that significantly extend the detection window. **Focusing on metabolite…
This automated system significantly enhances the capabilities of anti-doping programs. By enabling reliable, quantitative analysis from Dried Blood Spot samples, it makes collection less invasive and sample handling more efficient. For athletes and biohacke…
Looking for vendor-level purity, endotoxin, and HPLC data on GHRP-2 or GHRP-6? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.